Your doctor looks at you across the desk. “Six months or less to live.”
Those words change everything. They set in motion decisions about treatment, about time, about saying goodbye. In some places now, they open the door to Medical Aid in Dying—a legal option for ending your life with medical assistance. The timing matters because eligibility depends on that prognosis, that medical prediction of when death will arrive.
Here’s what most people don’t know: that six-month prediction carries no guarantee. None. Medical professionals openly acknowledge that prognosis—the medical term for predicting how long someone has to live—remains more art than science. The Centers for Medicare and Medicaid Services, which oversees hospice care in the United States, recognizes this uncertainty so clearly that patients can remain on hospice services for years beyond their initial six-month prognosis.
Think about that. Years.
When Medical Aid in Dying legislation makes terminal prognosis the gatekeeper for who can choose physician-assisted death, we’re building life-ending decisions on a foundation that shifts like sand. The question becomes urgent: are people choosing to die based on predictions no more reliable than next month’s weather forecast?
The Art of Predicting Death
Why Six Months Means Something Different
Doctors don’t have crystal balls. When a physician certifies that someone has six months or less to live, they’re making what hospice professionals call “an educated guess based on disease patterns, clinical observations, and experience with similar patients.” The word “certified” sounds official, sounds certain. It isn’t.
Weather forecasters use atmospheric pressure, humidity, historical patterns, and sophisticated computer models to predict rainfall. They still get it wrong. Medical prognostication works similarly, examining disease progression, lab values, functional decline, and symptom burden to estimate remaining time. The difference? When the weather forecast misses, you carry an umbrella you didn’t need. When a terminal prognosis misses, the stakes soar higher.
Prognostic assessment in hospice care demands both scientific precision and clinical artistry, according to hospice training materials. Notice that word: artistry. Art involves interpretation, subjective judgment, and individual skill. Science deals in measurables, in reproducibility, in certainty. Calling prognosis an art admits something critical—it comes with no guarantees.
The American Council on Science and Health noted in their analysis of Medical Aid in Dying legislation that prognostic uncertainty creates a fundamental problem when terminal prognosis serves as the primary eligibility criterion. They’re being diplomatic. The problem isn’t just fundamental; it’s potentially fatal for people who might have lived longer.
Hospice Shows Us What We Already Know
Hospice eligibility requires a physician to certify that if the illness runs its normal course, the patient will likely die within six months. But here’s the reality practiced thousands of times daily across American healthcare: “If someone lives longer than six months, they don’t get kicked out of hospice. As long as their condition still appears terminal and they continue to meet eligibility criteria, they can stay on hospice care.”
Read that again. Patients receive hospice for initial 90-day periods, then subsequent 60-day periods, with unlimited renewals. The average hospice stay runs about three weeks, yet many patients remain in hospice care for months beyond their initial prognosis, some even for years. This happens so commonly that Medicare built the recertification system around acknowledging prognostic limitations.
During recertification visits, hospice nurses document changes in condition, including eating and drinking patterns, mobility, new symptoms, weight changes, and overall energy and alertness. They’re not checking whether the original timeline was accurate. They’re assessing whether the patient still appears to have a terminal condition. The distinction matters enormously.
The Centers for Medicare and Medicaid Services—the federal agency that sets hospice standards—acknowledges explicitly that “the art of prognosis is fallible.” They built flexibility into hospice regulations precisely because medical professionals cannot predict death with precision. When the agency responsible for hospice oversight admits that prognosis involves guesswork, we should pay attention.
When Medical Science Meets Messy Reality
Disease trajectories—the paths illnesses follow as they progress—vary wildly even among patients with identical diagnoses. Two people with stage four pancreatic cancer might have drastically different timelines. Four people with end-stage heart failure might decline at four different speeds. Medical textbooks describe typical progression patterns, but individual patients don’t read them.
Functional decline patterns prove equally unpredictable. The Palliative Performance Scale and Karnofsky Performance Status measure how well someone can care for themselves and perform daily activities. These scores help determine hospice eligibility. A score of 50 or less on the Karnofsky scale generally indicates a life expectancy of 6 months or less.
Generally.
Hospice nurses learn quickly that “some patients follow atypical trajectories” and that “individual resilience” can lead patients to “outlive expectations due to personal factors.” One hospice training guide warns against common pitfalls in prognostic assessment, including “overreliance on single indicators” and “failing to acknowledge uncertainty.” Translation: even experienced professionals using evidence-based tools get prognoses wrong regularly enough that avoiding overconfidence counts as essential training.
The velocity of decline provides valuable prognostic information—changes occurring several times daily suggest hours to days remaining; changes every one to two weeks indicate weeks to months; monthly changes point to longer timeframes. Except when they don’t. Hospice professionals document numerous cases where rapid decline suddenly plateaus, where monthly decline accelerates unexpectedly, and where “paradoxically, some patients’ conditions stabilize with hospice support.”
Disease progression, comorbidities, nutritional status, symptom burden, and functional status—hospice nurses systematically evaluate these factors. They use validated assessment tools. They document meticulously. They consult with physicians. And they still acknowledge that determining terminal prognosis remains “one of the most challenging aspects of end-of-life care.”
Making Life-Ending Decisions on Shaky Ground
The Problem with MAiD Eligibility
Medical Aid in Dying legislation across North America makes a terminal prognosis the primary gatekeeper for eligibility. Most laws require certification from healthcare providers that the person has six months or less to live. New York’s proposed legislation follows this pattern, requiring physicians to determine that the patient has a terminal illness expected to cause death within six months.
Stop. Think about what that means.
A person requests assistance in ending their life. A physician evaluates their condition and determines they have six months or less remaining. Based largely on that prediction—that inherently uncertain, frequently inaccurate prediction—the person becomes eligible for medications that will end their life. The decision is irreversible. Death is permanent.
The American Council on Science and Health identified this as a critical flaw in Medical Aid in Dying legislation: “These individuals rely, at least in part, on a prognosis from a healthcare provider—a prediction often no more accurate than a weather forecast.” They’re not exaggerating for effect. The medical literature repeatedly documents that prognostic accuracy remains poor even among experienced physicians.
When hospice eligibility is based on a wrong prognosis, patients continue receiving comfort care. Support continues. Life continues. When Medical Aid in Dying eligibility is based on a wrong prognosis, there’s no recertification visit within 60 days. The patient who might have lived six more months, twelve more months, or eighteen more months died based on medical guesswork.
Stories That Haunt Us
Kiano was young. Healthy-looking by most standards. He struggled with depression, a mental health condition that often responds to treatment given time and appropriate care. Initially denied approval for Medical Aid in Dying, he persisted in his request. Eventually, Canadian authorities approved his application.
He was 26 years old. His physical body functioned normally. The term “terminal prognosis” stretches beyond recognition when applied to someone whose only life-threatening condition is treatable mental illness. Yet the system that initially said no eventually said yes.
Canadian data reveals that Medical Assistance in Dying now accounts for over five percent of all deaths in the country. That percentage represents thousands of individual decisions, thousands of prognoses, thousands of people who believed they had limited time remaining. How many of those prognoses were accurate? How many people died months or years before their bodies would have failed naturally?
We don’t track that. Once someone dies through Medical Aid in Dying, there’s no autopsy or prognosis, no review asking whether this person truly had six months or less remaining. The prediction never faces accountability.
Hospice care proves that prognostic inaccuracy cuts both ways. Some patients decline faster than expected. Others stabilize. Still others improve temporarily before final decline. When the prediction errors toward longer life, Medical Aid in Dying has already prevented that additional time from existing.
The Questions Nobody Wants to Ask
Are we ending recoverable lives? The question feels harsh. Uncomfortable. It needs asking.
Mental health conditions fluctuate. Depression responds to treatment. Anxiety can be managed. Hopelessness is not a terminal diagnosis. When Medical Aid in Dying expands beyond physical terminal illness to include psychological suffering, prognostic uncertainty multiplies exponentially. Predicting which depression will respond to treatment and which won’t exceeds the capacity of current psychiatric practice.
Science. Medicine. Evidence-based practice. These terms carry weight, confer authority, and suggest certainty that they cannot deliver in prognostic contexts. A physician’s certification of terminal illness sounds official, sounds definitive. Behind that certification sits clinical judgment, pattern recognition, educated guesswork about disease trajectory and individual resilience.
The moral question gets buried under medical terminology. We say “terminal prognosis” when we mean “doctor’s best guess about when you’ll die.” We say “six months or less” when we mean “probably six months or less, though we’ve been wrong before, and this patient might live longer or shorter, and we acknowledge uncertainty even as we sign certification documents.”
Medical Aid in Dying asks people to make an irreversible choice based on reversible predictions. That asymmetry should trouble us more than it does.
When Death Becomes Cheaper Than Care
The Math That Should Disturb You
Canadian healthcare officials reported that Medical Assistance in Dying saved the healthcare system $136 million in 2021. Let that number settle. Healthcare systems operating under budget pressures discovered that helping people die costs substantially less than treating chronic illness, managing symptoms, and providing long-term care.
Most healthcare systems operate on what professionals call a “sick care” model—they treat people after illness develops rather than preventing disease. This model proves expensive. Chronic conditions require ongoing medication, regular appointments, hospital stays, rehabilitation, medical equipment, and home care services. Diabetes, heart failure, kidney disease, dementia—these conditions consume enormous healthcare resources over months and years.
Euthanasia requires substantially fewer resources. One appointment for assessment. Perhaps a second for reconsideration. Medications. The procedure itself. Then, healthcare costs for that patient drop to zero.
The economic incentive creates a disturbing dynamic. Healthcare administrators facing budget shortfalls see cost savings in Medical Aid in Dying programs. Politicians see reduced healthcare spending. Insurance companies see decreased payouts for expensive chronic disease management. Everyone saves money. Except that the patient saves nothing because the patient is dead.
This isn’t speculation. This isn’t a conspiracy theory. Canadian healthcare officials publicly released the $136 million figure, apparently viewing cost savings as a positive outcome worth celebrating. When death becomes a budget solution, when euthanasia appears as a line item in healthcare cost reduction strategies, the entire framework for medical decision-making shifts toward outcomes that benefit systems rather than patients.
Offering Death When Treatment Exists
A woman lay on a hospital stretcher in a Canadian hallway. Hospital crowding left her without a room, without adequate care, without effective pain management. Staff approached her with an offer: Medical Assistance in Dying. They offered death before they offered her adequate pain control, before they found her a proper hospital bed, before they explored treatment options that might address her suffering without ending her life.
Canadian veterans seeking mental health care for service-related trauma received similar offers from Veterans Affairs staff. Rather than connecting these veterans with psychiatric care, with PTSD treatment, with the support services they earned through their service, staff members suggested Medical Aid in Dying as a solution to their suffering. The suggestion wasn’t a one-time aberration—multiple veterans reported receiving these offers.
Housing instability and poverty appear increasingly as factors in Medical Aid in Dying applications. People living with disabilities face inadequate support services, inaccessible housing, insufficient income, and social isolation. When suffering stems largely from socioeconomic factors rather than medical conditions, offering euthanasia instead of housing assistance, income support, and community services represents a profound failure of social responsibility.
The pattern reveals itself clearly: systems offer death when treatment exists, when support services could address suffering, and when the person’s condition might improve with adequate resources. Medical Aid in Dying transforms from a last resort for truly terminal, untreatable suffering into a first-line response to healthcare system failures, inadequate mental health services, poverty, and disability discrimination.
The Organ Question
Medical journals published studies examining Medical Assistance in Dying’s “real impact” on organ donation rates. The framing tells you everything—researchers celebrated increased organ availability resulting from euthanasia programs. Patients choosing Medical Aid in Dying can donate organs immediately after death, providing fresher, more viable organs than those recovered from patients who die naturally.
Organ transplantation saves lives. Organ donation represents profound generosity. But celebrating increased organ harvesting from euthanasia patients creates troubling incentives. When organs become a benefit of Medical Aid in Dying programs, when transplant waiting lists shrink because euthanasia provides fresh organs, the pressure to expand these programs intensifies.
Transplant systems theoretically allocate organs based on medical need and compatibility. In practice, questions about fraud and preferential access persist. Organs sometimes go to those who can afford to pay rather than those in greatest medical need. When Medical Aid in Dying increases organ availability, ensuring equitable distribution becomes even more critical.
The ethical complexity multiplies. A person considering Medical Aid in Dying learns they could donate organs and could save lives through their death. Does this knowledge influence their decision? Should it? Family members facing a loved one’s suffering might see organ donation as finding meaning in loss. Or they might feel subtle pressure: your death could save others. The emotional and ethical terrain becomes impossible to navigate clearly.
Medical professionals should never face conflicting interests where a patient’s death provides medical benefits to others. The possibility of organ harvesting must remain completely separate from Medical Aid in Dying decisions. Whether that separation can be maintained when systems openly celebrate euthanasia programs as sources of transplantable organs remains an open and deeply troubling question.
What Actually Helps: Planning Ahead
Beyond Attorney Paperwork
Advance care planning involves more than signing legal documents, more than designating a healthcare power of attorney, more than checking boxes on a living will. Comprehensive planning requires thinking through specific scenarios, understanding medical options, clarifying values, and communicating wishes clearly to family members and healthcare providers.
You don’t need an attorney for effective advance care planning, though legal documents do matter. Health and life navigation specialists—professionals trained specifically in end-of-life planning—can guide you through decision-making about resuscitation, breathing support, artificial nutrition, pain management, and other critical medical interventions. These specialists help you understand what each choice means practically, what it looks like in real medical situations, and how it aligns with your values.
Medical powers of attorney designate someone to make healthcare decisions if you cannot. Financial powers of attorney designate someone to manage money and property. Both matter. Both require careful thought about who you trust, what authority they’ll have, and when that authority comes into effect. Choosing the wrong person or leaving instructions unclear can lead to family conflict, court battles, and decisions that don’t reflect what you would have wanted.
Advance directives should address specific interventions: CPR, mechanical ventilation, feeding tubes, antibiotics, dialysis, and hospitalization. Each choice deserves careful consideration of your values, your goals, and your definition of acceptable quality of life. Generic forms don’t adequately capture individual preferences. Detailed, personalized advance directives give your healthcare agent and medical team clear guidance about your wishes.
Most critically, advance care planning requires conversations. Talk with your healthcare agent about your values, your fears, and your hopes. Talk with family members so everyone understands your choices. Talk with your doctor about your prognosis and treatment options. Documentation matters, but communication matters more.
Comfort Without Compromise
Palliative Care Starts Earlier Than You Think
Palliative care focuses on relieving suffering and improving the quality of life for people with serious illnesses. Most people think palliative care means end-of-life care. Wrong. Palliative care can start at diagnosis, can continue alongside curative treatment, and can last for decades before death.
Eligibility for palliative care depends on symptom burden—how much suffering the disease causes—not on prognosis. You don’t need a terminal diagnosis. You don’t need to stop curative treatment. You simply need symptoms that affect your quality of life: pain, shortness of breath, nausea, fatigue, anxiety, and depression. If your illness causes suffering, palliative care can help.
Palliative care teams include doctors, nurses, social workers, chaplains, and other specialists who work together to address physical symptoms, emotional distress, spiritual concerns, and practical needs. They help coordinate care among multiple specialists, clarify treatment options, facilitate family meetings, and provide support for both patients and caregivers.
Most providers can manage symptoms effectively enough that you feel no worse than you would with a common cold. That comparison sounds too good to be true. It isn’t. Modern symptom management using appropriate medications, doses, and combinations can control pain, nausea, shortness of breath, and other distressing symptoms in most patients. Suffering is not inevitable at the end of life. Untreated suffering is a failure of medical care, not a necessary part of the experience.
Hospice Done Right
Hospice care provides specialized support for people in the final months of life. Medicare covers hospice care for people with six months or less to live, though, as we’ve discussed, that timeline is flexible, and patients can remain on hospice care much longer if they continue to meet eligibility criteria.
Early hospice enrollment provides more benefits than last-minute enrollment. Patients who start hospice with weeks or months remaining rather than just days have time to build relationships with their care team, get symptoms well-controlled, make decisions while thinking clearly, create meaningful final memories with family, and prepare emotionally and spiritually for death.
Research consistently shows that hospice patients experience better pain control, less time in the hospital, more time at home with family, greater control over their care, and improved quality of life compared to patients who don’t choose hospice. Family members who choose hospice for their loved ones report less regret about end-of-life decisions and experience less complicated grief after death.
Hospice provides 24/7 access to nurses who can answer questions and provide guidance. Team members visit regularly—nurses several times per week for complex cases, home health aides for personal care, social workers for emotional support, and chaplains for spiritual care. Medical equipment like hospital beds and wheelchairs, medications for symptom management, and medical supplies are all covered under the Medicare hospice benefit.
Quality time with loved ones, comfort without unnecessary medical interventions, support for both patient and family, death at home rather than in a hospital—these outcomes result from hospice care done right. When hospice starts early enough, when symptoms are well-managed, when families receive adequate support, the final months of life look entirely different from the suffering many people fear.
Moving Forward With Open Eyes
Your advance directive sits in a drawer somewhere, signed five years ago, never updated since your health situation changed. Pull it out. Read it. Does it still reflect your wishes? Update it now, while you’re healthy enough to think clearly about your values and choices. An outdated advance directive might be worse than none at all.
Treat prognoses with healthy skepticism. When a doctor tells you six months, hear “probably around six months, though it could be three or twelve, and we acknowledge significant uncertainty in this prediction.” Ask questions about the basis for the prognosis, about factors that might extend or shorten that timeline, and about how confident they feel in their estimate. Medical predictions aren’t facts; they’re educated guesses that deserve questioning.
Start palliative care early. Don’t wait until suffering becomes unbearable, until you’re too weak to participate in treatment decisions, until disease has stolen months you could have spent more comfortably. If you have serious illness-causing symptoms that affect your life, ask your doctor about a palliative care referral today. Adding palliative care to your treatment team costs nothing and improves outcomes across multiple measures.
Consider hospice sooner rather than later. The average hospice stay of three weeks means most patients wait too long, enroll too late, and miss out on the benefits that early hospice enrollment provides. If your doctor mentions hospice or if you have a life-limiting illness with symptoms that are becoming harder to manage, explore hospice options now. Starting hospice doesn’t mean giving up; it means choosing comfort and support during whatever time remains.
Approach Medical Aid in Dying with extreme caution. The compassion behind these laws is real—nobody wants to see people suffer. The limitations are equally real. Prognoses are frequently wrong. Systemic pressures push toward death over treatment. Alternatives exist that address suffering without ending life prematurely. Before making an irreversible choice based on an uncertain prediction, explore every option for managing symptoms, improving quality of life, and addressing the sources of suffering that might respond to treatment.
Medical decisions this important deserve time, deserve multiple opinions, deserve thorough exploration of alternatives. They deserve more certainty than current prognostic science can provide.
📚 This site uses Amazon Associate links, which means I earn a small commission when you purchase books or products through these links—at no extra cost to you. These earnings help me keep this website running and free from advertisements, so I can continue providing helpful articles and resources at no charge.
💝If you don’t see anything you need today but still want to support this work, you can buy me a cup of coffee or tea. Every bit of support helps me continue writing and sharing resources for families during difficult times. 💙
Compassion Crossing Academy — Free and paid online courses are available to teach caregivers, nurses, social workers, chaplains, end-of-life advocates, and educators, including death doulas, how to coordinate complex care confidently.
At present, no official organization oversees end-of-life doulas (EOLDs). Remember that some EOLDs listed in directories may no longer be practicing, so it’s important to verify their current status.
End-of-Life Doula Schools
The following are end-of-life (aka death doula) schools for those interested in becoming an end-of-life doula:
Compassion Crossing Academy isn’t a death doula school, but it offers some really unique classes that can help a death doula expand their business. It’s a great resource for those looking to grow and learn more in this meaningful field.
Remember that there is currently no official accrediting body for end-of-life doula programs. Certification only means one graduated from an unaccreditdd program. It’s advisable to conduct discovery sessions with any death doula school you’re considering—whether or not it’s listed here—to verify that it meets your needs. Also, ask questions and contact references, such as former students, to assess whether the school offered a solid foundation for launching your own death doula practice.
